Interestingly, these authors also found that TPI-1 has anticancer potential on B16 melanoma thanks to the described induction of IFN-γ and demonstrated that B16 tumor growth is inhibited following TPI-1 treatment. The gene discussed is IFNG; the disease is neoplasm.